Similarly, an increase in interleukin-6 levels was associated with a decline in cognitive functions according to MoCA, assessed between 1 year and 3 months, in patients with AIS or transient ischemic attack (TIA) [76]. This evidence concerns the gene IL6 and transient ischemic attack.